Spectral.DNC-N® is the first topical hair-loss treatment to employ 5% Nanoxidil®, a powerful new alternative to Minoxidil, a compound with high efficacy, low molecular weight, and no known side effects. It arms men and women with a powerful new tool against hair loss. The compounds used in Spectral.DNC-N, have shown in various clinical studies to promote hair growth and prevent hair loss through opening ion channels within cells, suppress dihydrotestosterone (DHT), prevent perifollicular fibrosis, provide antioxidant effects, prolong the anagen phase of hair follicles, increase expression of vascular endothelial growth factor, suppress protein-kinase-C (PKC) isozymes, and block chronic inflammation. 

These compounds may also exert beneficial effects on other processes that are not yet fully understood. The use of Nanosome technology helps to enhance the active transport of these substances significantly into the skin and to prolong their actions. 

The advanced therapy for hair regrowth treats continuously for over 12 hours—significantly longer than conventional alopecia treatments—due to our proprietary Nanosome encapsulation. 

An alternative to Minoxidil with multiple mechanisms of action

People disappointed with the limited scope of minoxidil solutions and foams often get better results from Spectral.DNC-N indicated for early to moderate stages of hair loss. This treatment takes a multilateral approach to hair growth and hair loss prevention.

Treatment for vertex and hairline  

Key compounds promote hair growth at the hairline as well as at the vertex. Azelaic Acid and Caffeine block dihydrotestosterone (DHT) associated with androgenetic alopecia, open ion channels in follicle cells, stimulate the anagen phase of hair follicles, and reduce scalp inflammation.